Shauna M. Sorrells Grant – Tips for a Successful Application
G2G is offering a virtual webinar with insights, tips and strategies for securing the SMS grant in 2022 and beyond, plus an opportunity for questions. A recording will be made available on our website after the event for those unable to join live.
Read MoreNon-Dilutive Funding: G2G’s Monthly GBG Report Highlights Call & Screen Share 2021
Every third Friday of the month, G2G hosts this monthly GBG Report Highlights call to give bioscience companies (i.e. therapeutics, diagnostics, medical device, digital health, etc.) the chance to learn about non-dilutive funding opportunities such as grants and BAAs that could accelerate company growth. We will share insights on current, upcoming and new non-dilutive federal government funding sources and related priorities and close with a Q&A session. To see our monthly GBG Reports please visit our GBG Reports page on our website.
Read MoreCancer Advocacy Conversation
The purpose of this event is for advocates and those impacted with cancer to dial in to learn about cancer advocacy efforts, how to be an effective advocate, promote key legislation, build grassroots community and support for advocates new to the process. We aim to build a long-term cancer advocacy support system and efficacy and would be honored to have you join us.
Read MoreNon-Dilutive Funding: G2G’s Monthly GBG Report Highlights Call & Screen Share 2021
Every third Friday of the month, G2G hosts this monthly GBG Report Highlights call to give bioscience companies (i.e. therapeutics, diagnostics, medical device, digital health, etc.) the chance to learn about non-dilutive funding opportunities such as grants and BAAs that could accelerate company growth. We will share insights on current, upcoming and new non-dilutive federal government funding sources and related priorities and close with a Q&A session. To see our monthly GBG Reports please visit our GBG Reports page on our website.
Read MoreNon-Dilutive Funding: G2G’s Monthly GBG Report Highlights Call & Screen Share 2021
Every third Friday of the month, G2G hosts this monthly GBG Report Highlights call to give bioscience companies (i.e. therapeutics, diagnostics, medical device, digital health, etc.) the chance to learn about non-dilutive funding opportunities such as grants and BAAs that could accelerate company growth. We will share insights on current, upcoming and new non-dilutive federal government funding sources and related priorities and close with a Q&A session. To see our monthly GBG Reports please visit our GBG Reports page on our website.
Read MoreNon-Dilutive Funding: G2G’s Monthly GBG Report Highlights Call & Screen Share 2021
Every third Friday of the month, G2G hosts this monthly GBG Report Highlights call to give bioscience companies (i.e. therapeutics, diagnostics, medical device, digital health, etc.) the chance to learn about non-dilutive funding opportunities such as grants and BAAs that could accelerate company growth. We will share insights on current, upcoming and new non-dilutive federal government funding sources and related priorities and close with a Q&A session. To see our monthly GBG Reports please visit our GBG Reports page on our website.
Read MoreNon-Dilutive Funding: G2G’s Monthly GBG Report Highlights Call & Screen Share 2021
Every third Friday of the month, G2G hosts this monthly GBG Report Highlights call to give bioscience companies (i.e. therapeutics, diagnostics, medical device, digital health, etc.) the chance to learn about non-dilutive funding opportunities such as grants and BAAs that could accelerate company growth. We will share insights on current, upcoming and new non-dilutive federal government funding sources and related priorities and close with a Q&A session. To see our monthly GBG Reports please visit our GBG Reports page on our website.
Read MoreNon-Dilutive Funding: G2G’s Monthly GBG Report Highlights Call & Screen Share 2021
Every third Friday of the month, G2G hosts this monthly GBG Report Highlights call to give bioscience companies (i.e. therapeutics, diagnostics, medical device, digital health, etc.) the chance to learn about non-dilutive funding opportunities such as grants and BAAs that could accelerate company growth. We will share insights on current, upcoming and new non-dilutive federal government funding sources and related priorities and close with a Q&A session. To see our monthly GBG Reports please visit our GBG Reports page on our website.
Read MoreNon-Dilutive Funding: G2G’s Monthly GBG Report Highlights Call & Screen Share 2021
Every third Friday of the month, G2G hosts this monthly GBG Report Highlights call to give bioscience companies (i.e. therapeutics, diagnostics, medical device, digital health, etc.) the chance to learn about non-dilutive funding opportunities such as grants and BAAs that could accelerate company growth. We will share insights on current, upcoming and new non-dilutive federal government funding sources and related priorities and close with a Q&A session. To see our monthly GBG Reports please visit our GBG Reports page on our website.
Read MoreNon-Dilutive Funding: G2G’s Monthly GBG Report Highlights Call & Screen Share 2021
Every third Friday of the month, G2G hosts this monthly GBG Report Highlights call to give bioscience companies (i.e. therapeutics, diagnostics, medical device, digital health, etc.) the chance to learn about non-dilutive funding opportunities such as grants and BAAs that could accelerate company growth. We will share insights on current, upcoming and new non-dilutive federal government funding sources and related priorities and close with a Q&A session. To see our monthly GBG Reports please visit our GBG Reports page on our website.
Read More